Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 15, 2017
01 nov. 2017 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on...
Foamix Reports Second Quarter 2017 Financial Results and Provides Business Update
08 août 2017 16h01 HE
|
Foamix, Ltd.
REHOVOT, Israel, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on...
Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for August 9
26 juil. 2017 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., July 26, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on...
Foamix to Present Corporate Overview at the Rodman & Renshaw 18th Annual Global Investment Conference
06 sept. 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
Foamix Reports Second Quarter 2016 Financial Results and Provides Business Update
10 août 2016 07h00 HE
|
Foamix, Ltd.
REHOVOT, Israel, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company...
Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, August 10
25 juil. 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., July 25, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
Foamix to Present at the BIO International Convention
01 juin 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting
31 mai 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
Foamix to Present Corporate Overview at the Jefferies 2016 Healthcare Conference
26 mai 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., May 26, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
Foamix Names Dr. Stanley Hirsch as Chairman, and Dr. Dalia Megiddo as a Member of the Board of Foamix Pharmaceuticals
16 mai 2016 08h00 HE
|
Foamix, Ltd.
REHOVOT, Israel and BRIDGEWATER, N.J., May 16, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...